Patents by Inventor Anthony Atkinson

Anthony Atkinson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5397694
    Abstract: This invention relates to a novel protease-inhibitor,--which we called GELIN--and to pharmaceutical and cosmetic preparations thereof, containing this compound. GELIN is an inhibitor of human and porcine leucocyte elastase and chymotrypsin. GELIN has specific antibiotic properties. It also relates to the novel use of EGLIN, another chymotrypsin-inhibitor in cosmetic preparations.
    Type: Grant
    Filed: October 24, 1991
    Date of Patent: March 14, 1995
    Assignee: Merck Patent GmbH
    Inventors: Anthony Atkinson, Asgar Electricwala, Roy T. Sawyer, Nils von Sicard, Gerard Voerman
  • Patent number: 5362653
    Abstract: In a method and apparatus for examining samples comprising individual objects (28) of macromolecular or similar size, or smaller, an instrument element (14) comprises a substrate (16) overlaid with a thin film layer (18) of a material that is electrically conductive and/or at last partly optically opaque. A discontinuity comprising an aperture (26) or an asperity is formed in or on the element (14) in a known location, and the sample (28) is brought to this discontinuity so that it is not necessary to search for the sample by scanning. Energy (e.g. electrical energy or light) is applied to the element (14) and, with the latter and the sample in intimate association, e.g. with the sample inside the aperture (26), changes in the radiation from the sample site resulting from the presence of the sample are detected.
    Type: Grant
    Filed: May 6, 1992
    Date of Patent: November 8, 1994
    Inventors: Robert J. G. Carr, David J. Clarke, Anthony Atkinson
  • Patent number: 5354676
    Abstract: A recombinant thermophilic NAD-dependent dehydrogenase having a hydrophobic amino acid at position 104 and/or 102. The enzymes are effective in catalysing the dehydrogenation of homologues of pyruvic acid of formula CnH.sub.2n+1 COCOOH, wherein n is>1, to homologues of lactic acid of formula CH.sub.n H.sub.2n+1 CHOHCOOH, wherein n is>1.
    Type: Grant
    Filed: October 24, 1991
    Date of Patent: October 11, 1994
    Assignees: The University of Bristol, Public Health Laboratory Service Board
    Inventors: William N. Chia, Anthony R. Clarke, Joseph J. Holbrook, Helen M. Wilks, Anthony Atkinson
  • Patent number: 5003693
    Abstract: A method of providing an electrical circuit wherein a carrier, which is a film of insulating plastic material with a circuit pattern thereon is supported in a mould and a moulding material is applied by the application of heat and pressure to provide a substrate so that the circuit is embedded in or within a three-dimensional surface of the moulded substrate.
    Type: Grant
    Filed: September 11, 1989
    Date of Patent: April 2, 1991
    Assignee: Allen-Bradley International Limited
    Inventors: Anthony Atkinson, Richard Gray, Oscar L. Denes
  • Patent number: 4957910
    Abstract: A method is provided for treating a viral infection in a subject by administering a surfactant and/or a steroid so as to produce a high concentration thereof in the systemic circulation. The method is particularly applicable to the treatment of HIV infections. The use of surfactants and/or steroids in the production of pharmaceutical compositions is described.
    Type: Grant
    Filed: March 8, 1988
    Date of Patent: September 18, 1990
    Assignee: Public Health Laboratory Service Board
    Inventors: Peter M. Sutton, Anthony Atkinson, Graham Lloyd
  • Patent number: 4912288
    Abstract: A method of providing an electrical circuit wherein a carrier, which is a film of insulating plastic material with a circuit pattern thereon is supported in a mould and a moulding material is applied by the application of heat and pressure to provide a substrate so that the circuit is embedded in or within a three-dimensional surface of the moulded substrate.
    Type: Grant
    Filed: July 1, 1987
    Date of Patent: March 27, 1990
    Assignee: Allen-Bradley International Limited
    Inventors: Anthony Atkinson, Richard Gray, Oscar L. Denes
  • Patent number: 4780412
    Abstract: Fibrinolytic enzymes are produced and then isolated from non-cancerous established cell lines, designated as BEB or GPK. These fibrinolytic enzymes differ from those produced by malignant cell lines.
    Type: Grant
    Filed: November 4, 1983
    Date of Patent: October 25, 1988
    Assignee: Public Health Lab Svc Bd. University Coll.
    Inventors: Anthony Atkinson, Asgar Electricwala, John B. Griffiths, Amy Latter, Patrick A. Riley, Peter M. Sutton
  • Patent number: 4767670
    Abstract: A chromatographic packing useful for the separation of oligonucleotides is disclosed. The packing includes an insert porous support particle and a silane bonded phase comprising a weak anion exchange group in close proximity to at least one polar non-ionic group.
    Type: Grant
    Filed: January 21, 1987
    Date of Patent: August 30, 1988
    Assignee: E. I. Du Pont de Nemours and Company
    Inventors: Geoffrey B. Cox, Anthony Atkinson, Peter A. D. Edwardson, Michael D. Scawen
  • Patent number: 4663285
    Abstract: A plasmid selected from(a) a plasmid conferring resistance to tetracyline (Tc.sup.r) and neomycin (Neo.sup.r) on a host, and being built up by the in vitro ligation of a Neo.sup.r non-chimeric plasmid and a Tc.sup.r non-chimeric plasmid,(b) a deletion, insertion or deletion/insertion derivative of a group (a) plasmid, or(c) a rearrangement derivative of a group (a) or group (b) plasmid are disclosed.The host may be a Bacillus, particularly Bacillus subtilis.
    Type: Grant
    Filed: December 6, 1983
    Date of Patent: May 5, 1987
    Assignee: The Public Health Laboratory Service Board
    Inventors: Alistair H. A. Bingham, Anthony Atkinson, Christopher J. Bruton
  • Patent number: 4546161
    Abstract: Affinity chromatography media are prepared by reacting mono or di-chloro triazine dyes with a solid support matrix containing free hydroxy or amino groups in the presence of an alkali metal hydroxide and an alkali metal salt. In the absence of cyanogen bromide activation, the linkage to the support is entirely via the triazine ring giving high and specific protein-binding capacity. Suitable support matrices include polymers and copolymers of agarose, dextrose, dextran and acrylamide with agarose being particularly preferred. Dye binding levels are much higher than those obtained in the presence of carbonates or bicarbonates.Mono-chlorotriazinyl dyes are bound at a pH which is preferably above 9.5. The reaction time is about 40-60 hours at room temperature, however this may be reduced if the reaction temperature is increased. Dichlorotriazinyl dyes are bound at pH 8 to 12.5 in a few hours at room temperature.
    Type: Grant
    Filed: October 26, 1983
    Date of Patent: October 8, 1985
    Assignee: The Secretary of State for Defence in Her Britannic Majesty's Government of the United Kingdom of Great Britain and Northern Ireland
    Inventors: Michael J. Harvey, Anthony Atkinson
  • Patent number: 4431544
    Abstract: A process for the high pressure liquid affinity chromatographic separation of at least one biological or related substance from a mixture in which the contact, washing and eluting phases are performed on a binding material made from a ligand, containing at least one of the groups anthraquinone, phthalocyanine or aromatic azo, coupled to a matrix through a spacer arm, the binding material being so constructed that at least one biological or related substance is retained on the binding material during the contact and washing phases. In one preferred embodiment the ligand is a reactive dye, especially a triazinyl dye, the matrix is agarose or silica and the spacer arm is a substituted aminohexyl group. The chromatographic procedure is preferably performed at 100-3500 psi, at a flow rate of 0.5-2.0 ml/min. The choice of washing and eluting solutions depends on the material to be separated. However buffer solution to wash the column and a desorbing agent to elute the material are preferred.
    Type: Grant
    Filed: April 26, 1982
    Date of Patent: February 14, 1984
    Assignee: The Public Health Laboratory Service Board
    Inventors: Anthony Atkinson, Christopher R. Lowe, Klaus Mosbach, David A. P. Small
  • Patent number: 4414327
    Abstract: A method for the estimation of an anilide in which the anilide is first hydrolyzed enzymatically to an aniline and then the quantity of the aniline produced is estimated spectrophotometrically preferably colorimetrically.The hydrolysis of the anilide may be catalyzed by any enzyme of the type, EC 3.5.1.13, known as aryl acylamidases. Preferably enzymes isolated from the cells of Pseudomonas fluorescens ATCC 39005 or Pseudomonas putida ATCC 39004 are employed.The aniline may be analyzed, for example, by conversion to an indamine, an indophenol or an indoaniline, followed by colorimetric analysis of the colored quinone-type compound produced. This conversion may take place in the presence of an oxidizing agent, such as a copper (II) salt, and/or a base, such as ammonia.A diagnostic kit to allow the routine use of the above method is also provided.
    Type: Grant
    Filed: December 1, 1981
    Date of Patent: November 8, 1983
    Assignee: Public Health Laboratory Service Board
    Inventors: Peter M. Hammond, Christopher P. Price, Michael D. Scawen, Anthony Atkinson
  • Patent number: 4385120
    Abstract: A thermostable glycerokinase enzyme useful in the detection and estimation of glycerol derivatives has a half-life in excess of 1 hour at 55.degree. C. at a protein concentration of less than 2 mg/ml and a pH of 7.8 .+-.0.5 in the absence of any substrate. The enzyme is produced by culturing at least one micro-organism which is capable of growth at a temperature of at least 50.degree. C. in a culture medium in which it will produce said enzyme, disrupting the resulting cells of the micro-organism to release the enzyme and separating the enzyme from the cell debris. The medium normally contains at least 0.1% glycerol but certain strains of micro-organism have been found to be capable of producing thermostable glycerokinase enzyme even in the absence of glycerol. The micro-organism is preferably a Bacillus organism, especially of the stearothermophilus species.
    Type: Grant
    Filed: July 16, 1981
    Date of Patent: May 24, 1983
    Assignee: The Secretary of State for Defence in Her Britannic Majesty's Government of the United Kingdom of Great Britain and Northern Ireland
    Inventors: Anthony Atkinson, Michael J. Comer
  • Patent number: 4342827
    Abstract: Glycerol dehydrogenase enzymes having exeptionally good thermal stability are produced by culturing novel strains of Bacillus stearothermophilus. Procedures for deriving and identifying suitable strains are described. The strains are grown in conventional culture media, preferably containing 0.05 to 4.0%, especially 0.1 to 1.0%, by weight of glycerol or a glycerol analogue at 40.degree.-65.degree. C. and pH 5 to 8. The enzyme is isolated by conventional cell disruption and separation techniques, and typically has a molcular weight of 240,000.+-.30,000, composed of four similar sub-units, and a specific activity of greater than 5 Units per mg protein at 30.degree. C. by the modified assay described. They may be stored as aqueous solutions or a freeze dried solids.The enzymes may be used for assay of serum triglycerides by conventional assay methods, but preferably by the nictotinamide adenine dinucleotide spectrophotometric assay at a pH of 7 to 8.8.
    Type: Grant
    Filed: May 22, 1979
    Date of Patent: August 3, 1982
    Assignee: Public Health Laboratory Service, Center for Applied Microbiology & Research
    Inventors: Anthony Atkinson, Christopher J. Bruton, Michael J. Comer, Richard J. Sharp